Stocks closed higher for a sixth day Friday, with the Dow Jones
Industrials and the S&P 500 both hitting record highs. After
underperforming much of the session, the Nasdaq Composite index
climbed late to pass the other major market gauges, overcoming an
earnings miss by Oracle (
) and lackluster reviews for Amazon.com's (
) new smartphone with new deal speculation and another well
received initial public offering boosted biotech stocks.
Volume surged Friday, especially over the final hour of the
session, with the monthly and quarterly expiration of equity and
commodity options and futures contracts today. There were no
economic reports released today.
Crude oil for August delivery settled 76 cents at $106.81 per
barrel while July natural gas was down 5 cents to $4.53 per 1
million BTU. August gold rose $2.30 to $1,316.60 per ounce while
July silver added 28 cents to finish at $20.95 per ounce. July
copper climbed 4 cents, settling at $3.12 per pound.
Here's where the U.S. markets stood at end-of-day:
Dow Jones Industrial Average up 25.62 (+0.15%) to 16,947.08
S&P 500 up 3.39 (+0.17%) too 1,962.87
Nasdaq Composite Index up 8.71 (+0.20%) to 4,368.04
Hang Seng Index up 0.11%
Shanghai China Composite Index up 0.15%
FTSE 100 Index up 0.25%
(+) KITE, Drug-maker soars in market debut, climbing nearly 75%
after pricing an upsized initial public offering of 7.5 mln share
at $17 each. Deal prices $1 over its expected price range, also
selling an extra 1.5 mln shares above initial plans.
(+) SHPG, Rejects three buyout offers from rival drugmaker
), one as high as $46 bln in cash and stock. ABBV is now
considering a fourth offer, two people with knowledge of matter
tell Bloomberg. ABBV also is higher.
(+) FLML, Reaches new 52-week high after U.S. regulators approve
Aug. 6 Prescription Drug User Fee Act date for the company's second
New Drug Application - reportedly an alternative treatment for
(-) MACK, Regains global development and commercialization
rights to its MM-121 prospective cancer treatment from Sanofi (
), which agreed to continue funding Phase II testing for the next
(-) HERO, Terminates drill-rig contract with Sonangol EP,
costing the company an estimated $91.8 million, after the Angolan
state-owned energy concern failed to secure the necessary visas for
its employees to work in the west African country.
(-) EMES, Prices secondary public offering of 3.52 mln equity
units at $109.06 each. Selling unitholders include Superior Silica
Resources, which cut its ownership by nearly 30% to 6.6 mln units,
or about 27.8% of the company.